Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Fernandez-Munoz, Hermogenes [1 ,2 ]
Plaza, Eva M. [1 ]
Miguel Rivera-Caravaca, Jose [1 ]
Jose Candela, Maria [1 ]
Romera, Marta [1 ,3 ]
De Arriba, Felipe [1 ]
Lozano, Maria L. [1 ]
Vicente, Vicente [1 ]
Heras, Inmaculada [1 ]
Castilla-Llorente, Cristina [1 ,4 ]
Rivera, Jose [1 ]
机构
[1] Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,CIBERER,IMIB Arrixaca, Murcia, Spain
[2] Hosp Univ Rafael Mendez, Serv Hematol & Hemoterapia, Lorca, Spain
[3] Hosp Univ Santa Lucia, Serv Hematol & Hemoterapia, Cartagena, Spain
[4] Inst Gustave Roussy, Serv Hematol, Villejuif, France
关键词
Buffy-coat; platelet-rich plasma; correct count increment; platelet transfusion; allogeneic hematopoietic cell transplant; whole blood derived platelets; platelet concentrates; bleeding outcomes; WHOLE-BLOOD; APHERESIS; INCREMENTS; REFRACTORINESS; ENGRAFTMENT; LEUKEMIA; EFFICACY; STORAGE; PLASMA; IMPACT;
D O I
10.1080/10245332.2018.1455434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Whole blood-derived platelet concentrates can be obtained by the platelet-rich plasma (PRP-PCs) or the buffy-coat (BC-PCs) method. Few studies have shown that BC-PCs display lower in vitro platelet activation, but scarce information exists regarding transfusion efficacy. We have performed a retrospective study assessing platelet transfusion in patients undergoing allogeneic hematopoietic cell transplantation (AHCT) in our clinic, before and after the implementation of BC-PCs. Methods: We reviewed clinical records corresponding to 70 PRP-PCs and 86 BC-PCs prophylactic transfusions, which were performed to 55 AHCT patients. Transfusion efficacy was assessed by the 24-h post-transfusion corrected count increment (24-h CCI) and bleeding events. Clinical factors affecting transfusion outcome were also investigated. Results: Clinical characteristics and the total number of platelet transfusions were similar among groups. Mean donor exposure was 5.8 and 5.0 in each single PRP-PCs and BC-PCs transfusion, respectively (p < 0.01). The 24-h CCI was significantly higher in patients transfused with BC-PCs than in those receiving PRP-PCs (8.3[2.7-13.4] vs. 4.7[1.3-8.1]; p < 0.01). Independent predictors of poor platelet transfusion response included diagnosis other than acute leukemia (HR 8.30; 95% CI 1.96-35.22; p = 0.004), splenomegaly (HR 8.75; 95% CI 2.77-27.60; p < 0.001), graft versus host disease prophylaxis different from cyclosporine A and methotrexate (HR 3.96; 95% CI 1.55-10.14; p = 0.004) and PRP-PCs transfusion (HR 4.54; 95% CI 1.72-12.01; p = 0.002). There were no differences between both groups regarding the bleeding events. Conclusion: In the AHCT setting, we hypothesize that BC-PCs transfusion, when compared to PRP-PCs, results in higher CCI and reduced donor exposure, but provides no significant benefit regarding bleeding outcome.
引用
收藏
页码:712 / 718
页数:7
相关论文
共 48 条
  • [1] White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods
    Dijkstra-Tiekstra, MJ
    van der Schoot, CE
    Pietersz, RNI
    Reesink, HW
    VOX SANGUINIS, 2005, 88 (04) : 275 - 277
  • [2] Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
    Solves, Pilar
    Sanz, Jaime
    Freiria, Carmen
    Santiago, Marta
    Villalba, Ana
    Gomez, Ins
    Montesinos, Pau
    Montoro, Juan
    Piana, Jose Luis
    Lorenzo, Jose Ignacio
    Puig, Nieves
    Sanz, Guillermo F.
    Sanz, Miguel Angel
    Carpio, Nelly
    ANNALS OF HEMATOLOGY, 2018, 97 (01) : 161 - 167
  • [3] Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
    Pilar Solves
    Jaime Sanz
    Carmen Freiria
    Marta Santiago
    Ana Villalba
    Inés Gómez
    Pau Montesinos
    Juan Montoro
    Jose Luis Piñana
    José Ignacio Lorenzo
    Nieves Puig
    Guillermo F Sanz
    Miguel Ángel Sanz
    Nelly Carpio
    Annals of Hematology, 2018, 97 : 161 - 167
  • [4] A pediatric prognostic score for patients undergoing allogeneic hematopoietic stem cell transplantation
    Arndt, Clemens
    Beck, James F.
    Gruhn, Bernd
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 509 - 515
  • [5] Risk Analysis of Falls in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Ueki, Satoko
    Ikegame, Kazuhiro
    Kozawa, Mariko
    Miyamoto, Junko
    Mori, Reiko
    Ogawa, Hiroyasu
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (04) : 396 - 399
  • [6] Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Wang, Qingwei
    Liu, Minyuan
    Zhang, Senlin
    Gao, Li
    Chu, Xinran
    Li, Bohan
    Cheng, Shengqin
    Tian, Yuanyuan
    Zhang, Yongping
    Hu, Yixin
    Li, Jie
    Lu, Jun
    Xiao, Peifang
    Liu, Hu
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2025, : 422 - 424
  • [7] Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Stanchi, Karin Melanie Cabanillas
    Vek, Julia
    Schlegel, Patrick
    Rupprecht, Joachim Vincent
    Flaadt, Tim
    Weber, Simone
    Michaelis, Sebastian
    Lang, Peter
    Handgretinger, Rupert
    Doering, Michaela
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (04) : 1089 - 1100
  • [8] Serum electrolyte changes at engraftment time in patients undergoing allogeneic hematopoietic stem cell transplantation
    Faghihi, Toktam
    Iravani, Masoud
    Sharnshiri, Ahmad Reza
    Hadjibabaie, Molouk
    Mousavi, Seyyed Asadolah
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    ANNALS OF TRANSPLANTATION, 2009, 14 (03) : 51 - 57
  • [9] The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation
    Li, Guining
    Liu, Feng
    Mao, Xiaolu
    Ho, Lihua
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (01) : 21 - 24
  • [10] Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention
    Baumann, Freerk T.
    Zopf, Eva M.
    Nykamp, Eike
    Kraut, Ludwig
    Schuele, Klaus
    Elter, Thomas
    Fauser, Axel A.
    Bloch, Wilhelm
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (02) : 148 - 156